Chronic Disease Day: Why Raising Awareness Matters for Craniopharyngioma Survivors
Every year on July 10, Chronic Disease Day shines a spotlight on the millions of people living with chronic illnesses. ... Read more
Momentum is Building: Reflections from the First MC4R Pathway Summit
Coming together to advance understanding of MC4R pathway diseases and acquired hypothalamic obesity. Bonnie (Ian’s ... Read more
Benign Is Not Fine. It’s Time to Rally for Research
May is Brain Tumor Awareness Month, and this month the Raymond A. Wood Foundation is ... Read more
Advancing Understanding of Hyperphagia in CP
New Study Sheds Light on Hyperphagia in Craniopharyngioma We’re thrilled to share the publication of ... Read more
Team RAWF Takes on NYC to Support Brain Tumor Survivors!
The streets of New York City were full of energy, optimism and determination as a dedicated group ... Read more
Hypothalamic Syndrome: Finally, a Way to Describe What We’ve Been Living
Recognizing hypothalamic syndrome offers new hope for understanding, preventing, and treating the complex challenges faced ... Read more
Medical ID Bracelets for Panhypopituitarism Patients
It’s a common question that comes up among Facebook support groups for brain tumor patients ... Read more
The Raymond A. Wood Foundation and NORD® Launch Natural History Study of Rare Hypothalamic-Pituitary Brain tumors.
Research study is open to participants worldwide to advance understanding and treatments these rare diseases ... Read more
Clinical Trial Participant Best Practices
As a Participant, it’s Important to Do Your Part to Maintain the Integrity of the ... Read more
Raymond A. Wood Foundation Reveals Caregiver Burden in Pioneering Craniopharyngioma Study
The Raymond A. Wood Foundation recently published its first research study entitled “Caregiver burden and ... Read more